Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 499 entries
View as:

The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06115499 Org: User:
Start: 08/13/24 End: 12/09/29 Due: 12/09/30

Radiation Therapy and High-Dose Corticosteroids in Treating Older Patients With Primary CNS Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00003278 Org: User:
Start: 03/31/98 End: 06/30/03 Due: 06/30/04

Vitamin D and Breast Cancer Biomarkers in Female Patients

Phase: N/A Priority: Normal
NCT ID: NCT01224678 Org: User:
Start: 10/31/10 End: 12/31/14 Due: 12/31/15

Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00899782 Org: User:
Start: 07/15/04 End: 02/15/22 Due: 02/15/23

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05677490 Org: User:
Start: 01/31/23 End: 11/08/28 Due: 11/08/29

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00516503 Org: User:
Start: 02/29/08 End: 01/31/10 Due: 01/31/11

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00006348 Org: User:
Start: 10/31/00 End: 09/30/01 Due: 09/30/02

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04533451 Org: User:
Start: 11/16/20 End: 05/31/27 Due: 05/31/28

Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02249949 Org: User:
Start: 02/11/15 End: 05/01/23 Due: 05/01/24

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission

Phase: N/A Priority: Normal
NCT ID: NCT00002768 Org: User:
Start: 06/30/96 End: 03/31/09 Due: 03/31/10

Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002889 Org: User:
Start: 05/31/97 End: 06/30/09 Due: 06/30/10

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01099449 Org: User:
Start: 06/30/10 End: 03/31/13 Due: 03/31/14

Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00002994 Org: User:
Start: 07/31/97 End: 04/30/02 Due: 04/30/03

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients with Stage II-III Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04137107 Org: User:
Start: 06/17/20 End: 12/31/26 Due: 12/31/27

Evaluation of Mammographic Breast Density in Participants with Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502

Phase: N/A Priority: Normal
NCT ID: NCT03609021 Org: User:
Start: 02/26/19 End: 07/18/22 Due: 07/18/23

Paclitaxel in Treating Women With Recurrent Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00003130 Org: User:
Start: 11/30/97 End: 01/31/06 Due: 01/31/07

Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003900 Org: User:
Start: 10/31/99 End: 03/31/06 Due: 03/31/07

Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00956813 Org: User:
Start: 10/31/09 End: 05/31/13 Due: 05/31/14

Study of Tumor Samples From Patients With Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00900328 Org: User:
Start: 09/30/08 End: 09/30/12 Due: 09/30/13

Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00059865 Org: User:
Start: 01/31/04 End: 02/29/08 Due: 02/28/09

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00006029 Org: User:
Start: 07/31/00 End: 02/28/07 Due: 02/28/08

Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00433550 Org: User:
Start: 05/31/07 End: 05/31/16 Due: 05/31/17

Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781]

Phase: N/A Priority: Normal
NCT ID: NCT00003381 Org: User:
Start: 07/31/98 End: 01/31/05 Due: 01/31/06

Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003674 Org: User:
Start: 12/31/98 End: 04/30/04 Due: 04/30/05

Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00080951 Org: User:
Start: 03/31/04 End: 02/29/08 Due: 02/28/09